Filing Details
- Accession Number:
- 0001209191-14-010950
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2014-02-14 17:29:05
- Reporting Period:
- 2013-05-14
- Filing Date:
- 2014-02-14
- Accepted Time:
- 2014-02-14 17:29:05
- Original Submission Date:
- 2013-05-16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534287 | Bioamber Inc. | BIOA | Industrial Organic Chemicals (2860) | 980601045 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1575781 | A. Michael Hartmann | C/O Bioamber Inc. 1250 Rene Levesque West, Suite 4110 Montreal A8 H3B4W8 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-14 | 10,000 | $0.00 | 16,720 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2013-05-14 | 10,000 | $0.00 | 5,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,000 | 2013-08-08 | 2017-05-09 | No | 4 | P | Direct |
Footnotes
- The reported securities are included within 10,000 Units purchased by the reporting person on May 14, 2013 for $10.00 per Unit in connection with the Issuer's initial public offering. Each Unit consists of one share of common stock and one warrant to purchase half of one share of common stock. The Units currently trade on the NYSE. The common stock and warrants comprising the Units will begin trading separately on June 10, 2013, at which time trading of the Units will be suspended and the Units will be de-listed. Each warrant will be exercisable during the period commencing on August 8, 2013 and ending at 5:30 p.m. on May 9, 2017 at an exercise price of $11.00 per whole share of common stock
- This Form 4/A amends the Form 4 filed on May 16, 2013, which inadvertently reported Common Stock Warrants (right to buy) under Disposed Derivative Securities.